Synthesis of 4,5-dihydroisoxazole-5-carboxylate derivatives
5.08 (dd, J = 10.4, 8 Hz, OCH, 1H), 4.26 (q, OCH2, 2H), 3.96 (t, OCH2, 2H), 3.60-3.57 (m, CH2, 2H),
2H), 3.97 (t, OCH2, 2H), 3.60-3.57 (m, CH2, 2H), 1.45-1.25 (m, 23H, CH2, CH3), 0.86 (t, CH3, 3H). 13C
1.65-1.27 (m, CH2, CH3, 13H), 0.86 (t, CH3, 3H). NMR (CDCl3, 100MHz) δ: 14.07, 14.11, 22.61, 25.97,
13C NMR (CDCl3, 100MHz) δ: 14.04, 14.09, 22.56, 29.12, 29.34, 29.35, 29.54, 29.57, 29.62, 29.64, 39.12,
25.92, 28.99, 31.73, 39.11, 61.93, 68.14, 76.67, 76.98, 61.97, 68.13, 76.67, 77.31, 77.80, 114.66, 120.76,
77.30, 77.85, 114.67, 120.80, 128.45, 155.56, 160.95, 128.46, 128.57, 155.71, 161.88, 170.44. LCMS: 404.05
170.39. LCMS: 334.24 [M+H]+. Elemental Analysis [M+H]+. Elemental Analysis(%): C-71.38; H-9.20;
(%): C-68.39; H-8.11; N- 4.15. Yield: 81%.
N- 3.42. Yield: 82%.
2.4d Ethyl 3-[4-(octyloxy)phenyl]-4,5-dihydroisoxazole-
5-carboxylate (4d): FT-IR (cm−1): 2920, 1733, 1418,
1354, 1309. H NMR (CDCl3, 400MHz) δ: 7.58 (d,
2.4g Ethyl 3-[4-(hexadecyloxy)phenyl]-4,5-dihydroi-
soxazole-5-carboxylate (4g): FT-IR (cm−1): 2931,
1738, 1421, 1350, 1303. H NMR (CDCl3, 400MHz)
1
1
J = 8.8 Hz, ArH, 2H), 6.88 (d, J = 8.8 Hz, ArH, 2H),
5.10 (dd, J = 10.4, 8 Hz, OCH, 1H), 4.24 (q, OCH2,
2H), 3.96 (t, OCH2, 2H), 3.60-3.57 (m, CH2, 2H),
1.41-1.25 (m, CH2, 15H), 0.86 (t, CH3, 3H). 13C NMR
(CDCl3, 100MHz) δ: 14.04, 14.08, 22.61, 25.96, 29.18,
29.29, 31.76, 39.11, 61.91, 68.15, 76.66, 77.30, 77.80,
77.85, 114.69, 120.82, 128.44, 155.54, 160.96, 170.38.
LCMS: 348.22[M+H]+. Elemental Analysis(%):
C-69.12; H-8.37; N- 4.01. Yield: 82%.
δ: 7.74 (d, J = 8.8 Hz, ArH, 2H), 6.96 (d, J = 8.8 Hz,
ArH, 2H), 5.14 (dd, J = 10.4, 8 Hz, OCH, 1H), 4.30
(q, OCH2, 2H), 4.00 (t, OCH2, 2H), 3.61-3.57 (m,
CH2, 2H), 1.53-1.20 (m, CH2, CH3, 31H), 0.87 (t,
CH3, 3H). 13C NMR (CDCl3, 100MHz) δ: 14.06, 14.07,
22.65, 25.70, 29.32, 29.40, 29.56, 29.62, 29.64, 29.69,
29.72, 29.76, 29.80, 31.39, 32.79, 61.45, 76.65, 77.17,
77.29, 80.01, 114.50, 114.39, 122.01, 128.29, 128.45,
156.48, 161.99, 170.76. LCMS: 459.15 M+. Elemental
Analysis(%): C-73.14; H-9.83; N- 3.02. Yield: 80%.
2.4e Ethyl 3-[4-(decyloxy)phenyl]-4,5-dihydroisoxa-
zole-5-carboxylate (4e): FT-IR (cm−1): 2917, 1732,
1401, 1353, 1264. 1H NMR (CDCl3, 400MHz) δ: 7.42
(d, J = 8.8 Hz, ArH, 2H), 6.88 (d, J = 8.8 Hz, ArH,
2H), 5.11(dd, J = 10.4, 8 Hz, OCH, 1H), 4.24 (q, OCH2,
2H), 3.96 (t, OCH2, 2H), 3.61-3.59 (m, CH2, 2H),
1.71-1.26 (m, CH2, CH3, 19H), 0.86 (t, CH3, 3H). 13C
NMR (CDCl3, 100MHz) δ: 14.03, 14.14, 22.64, 25.96,
29.27, 29.52, 31.85, 39.10, 61.91, 68.14, 68.30, 76.67,
77.31, 77.71 77.94, 114.66, 120.81, 128.35, 128.53,
155.54, 160.95, 170.39. LCMS: 376.24 M+. Elemental
Analysis(%): C-70.33; H-8.90; N- 3.71. Yield: 84%.
3. Results and Discussion
3.1 Mesomorphic Properties
The changes in phases were identified by Polarizing
Optical microscope (figure 1) and they were found to be
in agreement with DSC transition temperatures. All the
synthesized derivatives were found to exhibit Nematic
and Smectic phases. Smectic phase was typical in the
intermediate compounds 3a-g and Nematic phase was
found to be the typical phase in all the synthesized Isox-
azolines 4a-g. Smectic phase was found in compounds
2.4f Ethyl 3-[4-(dodecyloxy)phenyl]-4,5-dihydroisoxazole- with long chain homologues and Nematic phase was
5-carboxylate (4f): FT-IR (cm−1): 2917, 1740, 1419, exhibited by compounds with short alkyl chain. The
1
1357, 1307. H NMR (CDCl3, 400MHz) δ: 7.58 (d, change in the mesomorphic phases is due to changes in
J = 8.8 Hz, ArH, 2H), 6.89 (d, J = 8.8 Hz, ArH, 2H), the orientations and free rotation of the rings, and vari-
5.11 (dd, J = 10.8, 8 Hz, OCH, 1H), 4.25 (q, OCH2, ous orientations are stabilized at different temperatures
Figure 1. POM images of 3a at 22◦C, 3b at 24◦C, 5b at 9.8◦C, 5d at 24◦C and 5e at 25◦C.